HIV as a cause of giant cell hepatitis.
The 9-month-old daughter of human immunodeficiency virus (HIV)-seropositive parents presented with cholestasis and was found on liver biopsy to have giant cell hepatitis. No viral inclusions or particles were seen by light or electron microscopy. Ultrastructural studies of the liver biopsy demonstrated tubuloreticular structures in the endothelium and cylindrical confronting cisternae in inflammatory cells in the portal tracts. Serologic studies for hepatitis B, hepatitis A, and Epstein-Barr viruses were negative. Cytomegalovirus (CMV) was cultured from the urine, but buffy coat, nasopharyngeal, and liver cultures were negative and CMV antibody titer was low. The hepatitis responded dramatically to prednisone therapy. A repeat biopsy several months later revealed similar morphologic findings. AIDS was suspected on clinical and immunologic grounds, and was confirmed by the demonstration of HIV-specific IgG and IgM in serum. Five months after initial presentation, the infant developed Pneumocystis pneumonia, disseminated CMV infection, and died. This appears to be the first reported association of infantile giant cell hepatitis with HIV infection.
Witzleben
C L
CL
Department of Pathology, University of Pennsylvania Medical School, Children's Hospital of Philadelphia 19104.
Marshall
G S
GS
Wenner
W
W
Piccoli
D A
DA
Barbour
S D
SD
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D003586:Cytomegalovirus Infections / Q000150:complications; D005260:Female; D006505:Hepatitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007223:Infant; D008099:Liver / Q000473:pathology / Q000648:ultrastructure; D008854:Microscopy, Electron; D011020:Pneumonia, Pneumocystis / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use
D011241:Prednisone